TraitHigh for CPIC high-risk medicines when G6PD deficiency is confirmed
Medication-triggered red blood cell breakdown (G6PD)
Medication-triggered red blood cell breakdown (G6PD) is a genetic trait Biome reports in its medication response panel: G6PD deficiency can make red blood cells break down with certain medicines, including some malaria treatments, pegloticase for gout, and rasburicase used during cancer care.
- Category
- Medication response
- Markers
- G6PD genotype plus enzyme activity when genotype is variable or indeterminate
- Strength of evidence
- High for CPIC high-risk medicines when G6PD deficiency is confirmed
- DNA-test coverage
- Stronger with whole genome
Genes
How Biome reads this
Biome's whole-genome test reads this from one saliva sample, alongside all 3.2 billion letters of your DNA.
Biome DNA test →This page is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Genetic results describe tendencies and predispositions, not diagnoses. Always consult a licensed clinician before making decisions about your health, medications, or supplements.